ライフサイエンスコーパス: nuclear antigen

1 kinase 2 (CDK2), CDK4 and proliferating cell nuclear antigen.

2 nd the replication clamp, proliferating cell nuclear antigen.

3 ions and by immunochemical detection of Ki67 nuclear antigen.

4 ant acid phosphatase, and proliferating cell nuclear antigen.

5 t also had high levels of proliferative cell nuclear antigen.

6 er than expression of the latency-associated nuclear antigen.

7 companied by production of autoantibodies to nuclear antigens.

8 The Epstein-Barr nuclear antigen 1 (EBNA-1) is an important target for va

9 In those diseases, Epstein-Barr nuclear antigen 1 (EBNA-1) is constitutively expressed.

10 Epstein-Barr nuclear antigen 1 (EBNA-1) is the only viral protein con

11 mologous proteins such as Epstein-Barr virus nuclear antigen 1 (EBNA-1) of the related gamma-herpesvi

12 Though EBV nuclear antigen 1 (EBNA1) and EBV-encoded small RNAs (EB

13 s, but also efficiently present targeted EBV nuclear antigen 1 (EBNA1) and EBV-latent membrane protei

14 Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is essential for EBV episome m

15 Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the EBV-encoded nuclear ant

16 dentical to that found in Epstein-Barr virus nuclear antigen 1 (EBNA1) that interacts with the N-term

17 Epstein-Barr Virus (EBV) Nuclear Antigen 1 (EBNA1)-mediated origin of plasmid rep

18 d nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antigen 1 (EBNA1)] necessary to maintain and rep

19 Nrf2 interacted with KSHV latency-associated nuclear antigen 1 (LANA-1) and the host transcriptional

20 in cells expressing only latency-associated nuclear antigen 1 (LANA-1) protein, and in KSHV latently

21 he expression of the KSHV latency-associated nuclear antigen 1 (LANA-1; ORF73) and LANA-1 nuclear pun

22 express nuclear antigens [latency-associated nuclear antigen 1 (LANA1) and Epstein-Barr nuclear antig

23 ciated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) protein is constitutively expr

24 cooperatively with EBNA1 (Epstein-Barr virus nuclear antigen 1) at OriP.

25 cargos such as STAT1 and Epstein-Barr Virus Nuclear Antigen 1, as well as the influenza virus polyme

26 -LMPpoly has been generated that encodes EBV nuclear antigen-1 (EBNA1) fused to multiple CD8(+) T-cel

27 V viral capsid antigen positive Epstein-Barr nuclear antigen-1 positive serostatus at transplant (p =

28 ats (GAr) from the EBNA1 (Epstein-Barr virus nuclear antigen-1) protein, can trigger partial degradat

29 Inactivation of ESE components, EBV nuclear antigen 2 (EBNA2) and bromodomain-containing pro

30 EBV nuclear antigen 2 (EBNA2) and EBV nuclear antigen LP (EB

31 Activated Notch and EBV nuclear antigen 2 (EBNA2) both function as transcription

32 Epstein-Barr virus nuclear antigen 2 (EBNA2) regulation of transcription th

33 d latent viral Cyclin and latency-associated nuclear antigen 2 levels in PEL cells.

34 hich mimics CD40 signaling), and EBV-encoded nuclear antigen 3A (EBNA3A) and EBNA3C (which inhibit on

35 Epstein-Barr nuclear antigen 3C (EBNA 3C) is essential for B-cell imm

36 Epstein-Barr virus nuclear antigen 3C (EBNA3C) repression of CDKN2A p14(ARF

37 Epstein-Barr nuclear antigen 3C (EBNA3C), one of the essential EBV la

38 Proliferating cell nuclear antigen, a DNA sliding clamp, interacts with and

39 Here, we used proliferating cell nuclear antigen, a hub protein that mediates DNA replica

40 ence of NKT cells hepatic proliferating cell nuclear antigen and cyclin B1 decreased in mice injected

41 ntly (P < 0.05) inhibited proliferating cell nuclear antigen and cyclin D and caused considerable apo

42 ication factor C-Delta1N, proliferating cell nuclear antigen and DNA polymerase delta was found to re

43 d in the presence of both proliferating cell nuclear antigen and DNA, but the activity was not shut d

44 ation and associated with proliferating cell nuclear antigen and other components of the DNA replicat

45 Whereas association with proliferating cell nuclear antigen and participation in processive genome r

46 air via interactions with proliferating cell nuclear antigen and replication factor C (RFC).

47 nuclear antigen 1 (EBNA1) is the EBV-encoded nuclear antigen and sequence-specific DNA binding protei

48 associated with increased proliferating cell nuclear antigen and tenascin-C expression.

49 ration, and expression of proliferating cell nuclear antigen and tenascin-C.

50 Proliferating cell nuclear antigen and the checkpoint clamp Rad9-Rad1-Hus1

51 th the accessory proteins proliferating cell nuclear antigen and the clamp loader replication factor

52 We further show that proliferating cell nuclear antigen and the nucleosome compete for binding t

53 Immunostaining with proliferating cell nuclear antigen and Von Willebrand factor revealed delay

54 ly, these events promote the accumulation of nuclear antigens and activate innate sensors that drive

55 ays showed 15 IgG autoantibodies (10 against nuclear antigens) and 4 IgM autoantibodies that were dif

56 ylation-resistant form of proliferating cell nuclear antigen, and chromatin loading of FA core comple

57 human systems, MutSalpha, proliferating cell nuclear antigen, and replication factor C activate MutLa

58 for BrdU, the mature neuron marker neuronal nuclear antigen, and the astrocytic marker glial fibrill

59 ASMC proliferation (Ki67, proliferating cell nuclear antigen, and WST1 assays) and resistance to apop

60 Amerindians and tested for HHV-8 anti-latent nuclear antigen (anti-LANA) and antilytic antibodies by

61 onegative recipients was associated with EBV nuclear antigen antibody deficiency, polymorphic disease

62 Autoantibodies to nuclear antigens arise in human autoimmune diseases, but

63 by an increased number of proliferative cell nuclear antigen assay (PCNA)-positive cells even at days

64 Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expres

65 l characterization of the proliferating-cell-nuclear-antigen-associated factor p15(PAF), showing that

66 nti-double-stranded DNA and anti-extractable nuclear antigen autoantibodies following treatment with

67 leading strand, and PCNA (proliferating cell nuclear antigen) binds tightly to Pol delta and recruits

68 methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, and caspase-Glo 3/7

69 eration was assessed with proliferating cell nuclear antigen, CD1, and Ki67 markers and along with as

70 , mature dendritic cells, proliferating cell nuclear antigen+ cells, and monocyte chemoattractant pro

71 narily interacts with the proliferating cell nuclear antigen clamp loader replication factor C, DNA p

72 Proliferating cell nuclear antigen content and signal transducer and activa

73 and protein expression of proliferating cell nuclear antigen, cyclin D1, E-cadherin, beta-catenin, Dv

74 inding protects Set8 from proliferating cell nuclear antigen-dependent degradation during the cell cy

75 hPol delta in supporting proliferating cell nuclear antigen-dependent elongation of DNA chains, whic

76 es and is characterized by the production of nuclear antigen-directed autoantibodies (e.g., anti-dsDN

77 ere IgG seropositivity to Epstein-Barr virus nuclear antigen (EBNA) (random effects odds ratio [OR] 4

78 ated forms of CLEC3A in HEK-293 Epstein-Barr nuclear antigen (EBNA) cells.

79 blastoid Cell Lines (LCLs) requires four EBV nuclear antigen (EBNA) oncoproteins: EBNA2, EBNALP, EBNA

80 ent for expression of the Epstein-Barr Virus nuclear antigen (EBNA), making it particularly beneficia

81 Epstein-Barr virus (EBV) nuclear antigens EBNALP (LP) and EBNA2 (E2) are coexpres

82 EBV nuclear antigens (EBNAs) and LMP1 are EBV transcriptiona

83 EBV nuclear antigens (EBNAs) and membrane proteins constitut

84 d Cp, resulting in the expression of six EBV nuclear antigens (EBNAs) and the viral Bcl2 homologue BH

85 may ensure against overexpression of the EBV nuclear antigens (EBNAs) prior to the transcriptional re

86 EBV latent membrane proteins (LMPs) and EBV nuclear antigens (EBNAs), as well as nontranslated viral

87 oxyuridine incorporation, proliferating cell nuclear antigen expression, and histone H3 phosphorylati

88 tion-PCR and detection of latency-associated nuclear antigen expression, respectively, in cell lysate

89 sured by doublecortin and proliferating cell nuclear antigen expression, was also suppressed after ne

90 SINTE BRANCHED1/CYCLOIDEA/PROLIFERATING CELL NUCLEAR ANTIGEN FACTOR) family of DNA-binding proteins,

91 to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibo

92 responsible for unloading proliferating cell nuclear antigen from newly synthesized DNA.

93 NBN1, PCNA (proliferating nuclear antigen), GADD45A (DNA damage-inducible), RAD23A

94 roportionate increases in proliferating cell nuclear antigen gene expression.

95 , EBV latent membrane protein-1 and -2A, EBV nuclear antigen, HBV-encoded X antigen, and nonstructura

96 viral genes included the latency-associated nuclear antigen homolog ORF73 but none of the regions kn

97 tion was evaluated by proliferating cellular nuclear antigen immunoblotting.

98 ences in stabilization of proliferating cell nuclear antigen in an open conformation.

99 cyclin D1, E, and A, and proliferating cell nuclear antigen in meningeal cells while significantly r

100 or mono-ubiquitination of proliferating-cell nuclear antigen in response to oxidative DNA damage, whi

101 creased expression of proliferating cellular nuclear antigen in Sertoli cells were observed in Ppard(

102 ignificantly prevented reduction of neuronal nuclear antigen in the infarcted area, although no impro

103 conclusion, lower IgG autoantibodies against nuclear antigens in DLE+SLE+ versus DLE-SLE+ subjects su

104 tibodies, many of which are directed against nuclear antigens, in particular double-stranded (ds) DNA

105 n its recently identified proliferating cell nuclear antigen-interacting motif, which is required for

106 The conserved proliferating cell nuclear antigen-interacting protein box motif in yeast E

107 tion that p12 possesses a proliferating cell nuclear antigen-interacting protein-degron (PIP-degron)

108 ic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting

109 ct regions, including the proliferating-cell-nuclear-antigen-interacting protein motif (PIP-box) and

110 A conserved proliferating cell nuclear antigen interaction protein box of APE2 is impor

111 ch compete for binding to proliferating cell nuclear antigen, is critical to prevent genomic instabil

112 rmal thickening, blocked the accumulation of nuclear antigen Ki67(+) cells in the basal and the supra

113 we show that KSHV-encoded latency-associated nuclear antigen (LANA) disrupts the association of CIITA

114 increased numbers of KSHV latency-associated nuclear antigen (LANA) dots, as detected by immunofluore

115 The latency-associated nuclear antigen (LANA) encoded by Kaposi's sarcoma-assoc

116 The latency-associated nuclear antigen (LANA) encoded by KSHV plays a key role

117 hown to interact with the latency-associated nuclear antigen (LANA) encoded by KSHV.

118 KSHV latency by inducing latency-associated nuclear antigen (LANA) expression during early stages of

119 ls of mRNAs encoding KSHV latency-associated nuclear antigen (LANA) in primary effusion lymphoma (PEL

120 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a 1,162-amino-acid protein tha

121 Latency-associated nuclear antigen (LANA) is a conserved gamma-2-herpesviru

122 Latency-associated nuclear antigen (LANA) is a conserved Rhadinovirus prote

123 Latency-associated nuclear antigen (LANA) is a conserved, multifunctional p

124 Latency-associated nuclear antigen (LANA) is a multifunctional protein enco

125 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA) is a multifunctional protein with

126 Latency-associated nuclear antigen (LANA) is central to episomal tethering,

127 The latency-associated nuclear antigen (LANA) is central to the maintenance of

128 Latency-associated nuclear antigen (LANA) is one of the major proteins expr

129 Latency-associated nuclear antigen (LANA) is the most abundantly expressed

130 KSHV latency-associated nuclear antigen (LANA) mediates persistence of viral epi

131 The latency-associated nuclear antigen (LANA) of Kaposi sarcoma herpesvirus (KS

132 The latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associate

133 constitutively expressed latency-associated nuclear antigen (LANA) of the virus.

134 Using immunofluorescence labeling of latent nuclear antigen (LANA) protein, together with fluorescen

135 geted by the KSHV-encoded latency-associated nuclear antigen (LANA) to repress expression of the majo

136 KSHV latency-associated nuclear antigen (LANA) transcription levels rose consist

137 aposi sarcoma herpesvirus latency-associated nuclear antigen (LANA)(1-23), human papillomavirus 8 E2,

138 on of the virally encoded latency-associated nuclear antigen (LANA), a marker of latent KSHV infectio

139 Latency-associated nuclear antigen (LANA), a multifunctional protein expres

140 to the host chromosome by latency associated nuclear antigen (LANA), which binds in the terminal repe

141 mes are coated with viral latency-associated nuclear antigen (LANA).

142 teins such as herpesvirus latency-associated nuclear antigen (LANA).

143 long infections using its latency-associated nuclear antigen (LANA).

144 ciated herpesvirus (KSHV) latency-associated nuclear antigen (LANA).

145 This is dependent on the latency-associated nuclear antigen (LANA).

146 , such as ORCs, MCMs, and latency-associated nuclear antigen (LANA).

147 irus (KSHV) infection and latency-associated nuclear antigen (LANA-1) upregulate the multifunctional

148 ion and the expression of latency-associated nuclear antigen (LANA-1) upregulates the angiogenic mult

149 on of the highly abundant latency-associated nuclear antigen, LANA, on the host genome and its impact

150 BV) are human DNA tumor viruses that express nuclear antigens [latency-associated nuclear antigen 1 (

151 The diversity of the latency protein EBV nuclear antigen leader protein (EBNA-LP) resides predomi

152 replication factor C, and proliferating cell nuclear antigen, long leading strands (>10 kb) are produ

153 EBV nuclear antigen 2 (EBNA2) and EBV nuclear antigen LP (EBNALP) are critical for B-lymphocyt

154 ibosomal protein L16; in humans, MYC-induced nuclear antigen (MINA53; also known as MINA) and nucleol

155 ddress the role of MuHV-4 latency-associated nuclear antigen (mLANA) E3 ligase activity in gammaherpe

156 Here, we focused on latency-associated nuclear antigen (mLANA) encoded by murid herpesvirus-4 (

157 th induced Rad18-mediated proliferating cell nuclear antigen mono-ubiquitination during G(0), G(1) an

158 NA synthesis initiated by proliferating cell nuclear antigen monoubiquitination or less well-characte

159 s of DNA damage, inducing proliferating cell nuclear antigen monoubiquitination, and suppressing muta

160 hrenia and 38 control subjects) for neuronal nuclear antigen (NeuN+) and 65/67 kDa isoform of glutami

161 nt reduction in levels of proliferating cell nuclear antigen, NF-kappabeta/p50, cyclooxygenase-2, and

162 and of the 6 latency-associated EBV-encoded nuclear antigens, only EBNA3B is completely dispensable

163 polymerase sliding clamp, proliferating cell nuclear antigen or PCNA, is a ring-shaped protein comple

164 DNA substrates and either proliferating cell nuclear antigen or the checkpoint sliding clamp 9-1-1.

165 We found that fungal proliferating cell nuclear antigen-partner interaction networks diverged in

166 In yeast, the proliferating cell nuclear antigen PCNA (also known as Pol30) is modified b

167 n, which binds DNA-loaded proliferating cell nuclear antigen (PCNA(DNA)) and recruits CRL4(Cdt2).

168 During DNA replication, proliferating cell nuclear antigen (PCNA) adopts a ring-shaped structure to

169 Proliferating cell nuclear antigen (PCNA) and alpha-smooth muscle actin (al

170 expression of cyclins and proliferating cell nuclear antigen (PCNA) and evidence for DNA replication

171 sed platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 monoubiquitinations (s

172 53 increased the level of proliferating cell nuclear antigen (PCNA) and minichromosome maintenance 4

173 red box protein 7 (Pax7), proliferating cell nuclear antigen (PCNA) and nicotinamide phosphoribosyltr

174 on factories by retaining proliferating cell nuclear antigen (PCNA) and other replisome proteins on t

175 tone substrates including proliferating cell nuclear antigen (PCNA) and promotes carcinogenesis by de

176 ctions with two proteins, Proliferating Cell Nuclear Antigen (PCNA) and Replication Protein A (RPA),

177 ocessivity clamps such as proliferating cell nuclear antigen (PCNA) and the checkpoint sliding clamp

178 ication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffold protein Rev1.

179 nary complexes containing proliferating cell nuclear antigen (PCNA) and two non-classical DNA polymer

180 study, we identified the proliferating cell nuclear antigen (PCNA) as a nIGF-1R-binding partner.

181 hat the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates with the C-terminal do

182 Here, we investigated proliferating cell nuclear antigen (PCNA) binding and opening by the Saccha

183 F-1 p150 was deficient in proliferating cell nuclear antigen (PCNA) binding, reinforcing the existenc

184 and polyubiquitination of proliferating cell nuclear antigen (PCNA) by regulating the recruitment of

185 tethering of Polkappa to proliferating cell nuclear antigen (PCNA) circumvents the need for its ubiq

186 t events in the reaction: proliferating cell nuclear antigen (PCNA) clamp binding/opening/closure/rel

187 C) complex loads circular proliferating cell nuclear antigen (PCNA) clamps onto DNA where they serve

188 ubunit complex that loads proliferating cell nuclear antigen (PCNA) clamps onto primer-template DNA (

189 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) clamps using single-molecule appr

190 cle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) compared with 2- and 3-copy mice.

191 yuridine (BrdU) labeling, proliferating cell nuclear antigen (PCNA) expression and mitotic index incr

192 bp1), a key in regulating proliferating cell nuclear antigen (PCNA) expression and ribosomal RNA (rRN

193 lpha/beta, and DNA-loaded proliferating cell nuclear antigen (PCNA) for activation.

194 Proliferating cell nuclear antigen (PCNA) forms a trimeric ring that associ

195 Proliferating cell nuclear antigen (PCNA) forms a trimeric ring that encirc

196 ATM co-precipitates with proliferating cell nuclear antigen (PCNA) from cellular extracts.

197 eling as well as Ki67 and proliferating cell nuclear antigen (PCNA) immunofluorescence, we determined

198 Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) in replication factor C (RFC)-cat

199 the sliding clamp protein proliferating cell nuclear antigen (PCNA) in response to DNA damage, exhibi

200 h consists of a canonical proliferating cell nuclear antigen (PCNA) interaction motif (PIP box) and a

201 Proliferating cell nuclear antigen (PCNA) is a critical player in cell prol

202 Proliferating cell nuclear antigen (PCNA) is a highly conserved protein nec

203 Proliferating cell nuclear antigen (PCNA) is a protein which is involved in

204 Proliferating cell nuclear antigen (PCNA) is a ring-shaped protein that enc

205 Proliferating cell nuclear antigen (PCNA) is a ubiquitous protein that inte

206 Proliferating cell nuclear antigen (PCNA) is an essential component for DNA

207 The sliding clamp proliferating cell nuclear antigen (PCNA) is an indispensable component of

208 Proliferating cell nuclear antigen (PCNA) is required for DNA homologous re

209 The sliding clamp protein proliferating cell nuclear antigen (PCNA) is situated at the core of the eu

210 Proliferating cell nuclear antigen (PCNA) lies at the center of the faithfu

211 Proliferating cell nuclear antigen (PCNA) loading by replication factor C (

212 erturbation that supports proliferating cell nuclear antigen (PCNA) loading by replication factor C,

213 se and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto DNA (PCNA(DNA)) trig

214 omotrimeric sliding clamp proliferating cell nuclear antigen (PCNA) mediates Okazaki fragment maturat

215 se RAD18 is necessary for proliferating cell nuclear antigen (PCNA) monoubiquitination and TLS polyme

216 7 promoted the UV-induced proliferating cell nuclear antigen (PCNA) monoubiquitination in Poleta-prof

217 FANCD2 can still support proliferation cell nuclear antigen (PCNA) monoubiquitination.

218 ependent kinase (CDK) and proliferating cell nuclear antigen (PCNA) onto chromatin, as well as initia

219 The sliding clamp proliferating cell nuclear antigen (PCNA) plays a vital role in a number of

220 Proliferating cell nuclear antigen (PCNA) plays an important role in both m

221 wn that monoubiquitinated proliferating cell nuclear antigen (PCNA) plays an important role in recrui

222 raction between RECQ5 and proliferating cell nuclear antigen (PCNA) promotes RAD18-dependent PCNA ubi

223 P-box sequence peptide to proliferating cell nuclear antigen (PCNA) protein by competing for the same

224 mplate and anchors to the proliferating cell nuclear antigen (PCNA) sliding clamp to form a holoenzym

225 synthesizing DNA with the proliferating cell nuclear antigen (PCNA) sliding clamp; however, it has re

226 evels of doublecortin and Proliferating Cell Nuclear Antigen (PCNA) suggested increased neurogenesis.

227 of the DNA clamp protein proliferating cell nuclear antigen (PCNA) to DNA lesions.

228 DNA damage-induced proliferating cell nuclear antigen (PCNA) ubiquitination serves as the key

229 titutively interacts with proliferating cell nuclear antigen (PCNA) via a highly conserved PIP box mo

230 brain mantle and express proliferating cell nuclear antigen (PCNA), a cell cycling marker, indicate

231 RV2) and the host-encoded proliferating cell nuclear antigen (PCNA), a key DNA replication protein in

232 ow that monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA), a marker of stalled replication

233 cently described that the proliferating cell nuclear antigen (PCNA), a nuclear factor involved in DNA

234 Proliferating cell nuclear antigen (PCNA), a potential anticancer target, f

235 acidophilum interact with proliferating cell nuclear antigen (PCNA), an essential co-factor for DNA p

236 the recruitment of Cdc45, proliferating cell nuclear antigen (PCNA), and polymerase delta, but not OR

237 y stabilization of Mcl-1, proliferating cell nuclear antigen (PCNA), and pro-caspase-3.

238 Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replication factor C (RFC) a

239 Proliferating cell nuclear antigen (PCNA), bone sialoprotein (BSP), osteoca

240 complex monoubiquitinates proliferating cell nuclear antigen (PCNA), but the basis for recruitment of

241 erase processivity factor proliferating cell nuclear antigen (PCNA), complexed onto DNA.

242 n A, pRb (Ser249/Thr252), proliferative cell nuclear antigen (PCNA), cyclin D1 with elevated levels o

243 age and monoubiquitinates proliferating cell nuclear antigen (PCNA), facilitating engagement of Polet

244 nding capability of human proliferating cell nuclear antigen (PCNA), identified the lysine residue in

245 ability to interact with proliferating cell nuclear antigen (PCNA), it enhances its interaction with

246 ith the replication clamp proliferating cell nuclear antigen (PCNA), respectively.

247 Increased expression of proliferating cell nuclear antigen (PCNA), TGF-beta, and p-AKT and decrease

248 The proliferating cell nuclear antigen (PCNA), the auxiliary factor of nuclear

249 1 inhibits recruitment of proliferating cell nuclear antigen (PCNA), the platform for assembly of the

250 Proliferating cell nuclear antigen (PCNA), the processivity factor for DNA

251 mbly might be governed by proliferating cell nuclear antigen (PCNA), the processivity factor of repli

252 eplicative sliding clamp, proliferating cell nuclear antigen (PCNA), the UBZ domain facilitates recru

253 its are also required for proliferating cell nuclear antigen (PCNA)-dependent TLS by Pol zeta as Pol

254 Lack of SIM, but not proliferating cell nuclear antigen (PCNA)-interacting motif (PIM), leads to

255 Enok complex and the Elg1 proliferating cell nuclear antigen (PCNA)-unloader complex.

256 e interaction of TDG with proliferating cell nuclear antigen (PCNA).

257 equence alteration of the proliferating cell nuclear antigen (PCNA).

258 g-shaped homotrimeric proliferating cellular nuclear antigen (PCNA).

259 y their interactions with proliferating cell nuclear antigen (PCNA).

260 ractions between TXR1 and proliferating cell nuclear antigen (PCNA).

261 lisome through binding to proliferating cell nuclear antigen (PCNA).

262 ith the replication clamp proliferating cell nuclear antigen (PCNA).

263 on the DNA sliding clamp, proliferating cell nuclear antigen (PCNA).

264 by the ubiquitination of proliferating cell nuclear antigen (PCNA).

265 iggered by DNA binding of proliferating cell nuclear antigen (PCNA).

266 n of Nox4, TNF-alpha, and proliferating cell nuclear antigen (PCNA).

267 ance the transcription of proliferating cell nuclear antigen (PCNA).

268 d by its interaction with proliferating cell nuclear antigen (PCNA).

269 ll molecule inhibitors of proliferating cell nuclear antigen (PCNA)/PCNA interacting protein box (PIP

270 ocessivity clamps such as proliferating cell nuclear antigen (PCNA); however, the exact mechanism of

271 e heterotrimeric PCNA123 [proliferating cell nuclear antigen (PCNA)] clamp onto DNA that includes a r

272 tivity (analyses of Ki67, proliferating cell nuclear antigen, phosphorylated histone 3, mitosis, and

273 e-positive cells and more proliferating cell nuclear antigen-positive cells in all treatment groups r

274 lso showed an increase in proliferating cell nuclear antigen-positive renal tubules.

275 (P < 0.05) the number of proliferating cell nuclear antigen-positive tubular epithelial cells at 24

276 raction between XEco2 and proliferating cell nuclear antigen prevents cohesion establishment while ha

277 IgG:IgM ratios of autoantibodies against nuclear antigens progressively rose from healthy to DLE-

278 report an ancient family of GCNA (germ cell nuclear antigen) proteins that arose in the earliest euk

279 on polyubiquitylation of proliferating cell nuclear antigen provides a backup mechanism for accurate

280 tional inner mitochondrial enzymes, and four nuclear antigens remain immunologically intact with resp

281 tive DNA polymerase delta/proliferating cell nuclear antigen/replication factor C complex on telomeri

282 ell cycle (e.g. P. patens proliferating cell nuclear antigen, ribonucleotide reductase, and minichrom

283 lation of chromatin-bound proliferating cell nuclear antigen, slowed cell division, and increased gen

284 EBNA1 is the EBV-encoded nuclear antigen that is consistently expressed in all EB

285 Unlike proliferating cell nuclear antigen, the interaction with RFC is regulated b

286 replication factor C and proliferating cell nuclear antigen to perform efficient DNA synthesis in vi

287 stimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase assays; and gene exp

288 tions and perform IHC for proliferating cell nuclear antigen, upstream binding factor, RNA polymerase

289 n by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18 and UBC13-MMS2-RAD

290 estasis, but unexpectedly proliferating cell nuclear antigen was down-regulated at 12 days after chol

291 LR assessed by Ki-67 and proliferating cell nuclear antigen was markedly decreased in Itpr2(-/-) mic

292 ce, whereas cyclin D1 and proliferating cell nuclear antigen were decreased to reduce cell proliferat

293 ant acid phosphatase, and proliferating cell nuclear antigen were evaluated by histochemical and immu

294 of hepatic cyclin B1 and proliferating cell nuclear antigen were evaluated by Western Blot and liver

295 Ki-67 and proliferating cell nuclear antigen were used to measure hepatocytes prolife

296 cated by co-staining with proliferating cell nuclear antigen, whereas Notch3 was expressed throughout

297 NANCE 2-7 gene family and PROLIFERATING CELL NUCLEAR ANTIGEN, which encode essential DNA replication

298 Nuclear antigens, which activate dendritic cells (DCs),

299 the proliferation marker proliferating cell nuclear antigen while also displaying a reduction in epi

300 ractions of S. cerevisiae Proliferating Cell Nuclear Antigen (yPCNA) with modified DNA sequences and